Thompson Davis & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-500
Closed -$6K 1143
2014
Q2
$6K Buy
+500
New +$6K 0.01% 571